CYP 0.00% 66.0¢ cynata therapeutics limited

On track for Phase 2 clinical trials

  1. 471 Posts.
    lightbulb Created with Sketch. 34

    Cynata Therapeutics (ASX:CYP) on track for Phase 2 clinical trials



    • Cynata Therapeutics (CYP) has released its December 2019 quarterly report, primarily outlining positive operations
    • Highlights for the biotech company include planning multiple Phase 2 clinical trials and receiving a notice of allowance from the Canadian Intellectual Property Office
    • Moving forward with the Phase 2 trials places Cynata one step closer to commercialising its products

    Click to view full article

 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
(20min delay)
Last
66.0¢
Change
0.000(0.00%)
Mkt cap ! $94.56M
Open High Low Value Volume
66.5¢ 66.5¢ 64.0¢ $187.5K 288.2K

Buyers (Bids)

No. Vol. Price($)
1 16084 64.0¢
 

Sellers (Offers)

Price($) Vol. No.
67.0¢ 50000 2
View Market Depth
Last trade - 15.42pm 05/03/2021 (20 minute delay) ?
(live)
Last
64.0¢
  Change
0.000 ( 3.03 %)
Open High Low Volume
65.0¢ 65.0¢ 63.5¢ 9734
Last updated 15.57pm 05/03/2021 (live) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.